Mareike Lohse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mareike Lohse has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
- Holger Taschenberger
Department of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany
2 shared publications - Nils Brose
Department of Molecular Neurobiology Max Planck Institute for Multidisciplinary Sciences Göttingen Germany
2 shared publications - Noa Lipstein
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
2 shared publications - Aaron D. Gitler
Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
1 shared publication - Abolfazl Rad
Arcensus GmbH, Rostock, Germany
1 shared publication Aditi Dagli
Division of Medical Genetics, Arnold Palmer Hospital Orlando Health, Orlando, USA
1 shared publication
Latest Publications
- Open Access
- 13 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (7) , eaea0449
Munc13-1 couples DAG and Ca 2+ signaling to dynamic vesicle priming, synaptic short-term plasticity, and posttetanic potentiation
Synaptic strength and plasticity are fine-tuned by neuromodulation and use-dependent second-messenger signaling. Presynaptic diacylglycerol (DAG), Ca 2+ , and Ca 2+ -calmodulin signaling converge on the essential synaptic vesicle (SV) priming protein Munc13-1 via its regulatory C 1 , C 2 B, and CaM-binding domains. Using brainstem-specific heterozygous mice expressing a DAG-binding-deficient Munc13-1 variant (Munc13-1 H567K ), we compared synaptic transmission in situ at glutamatergic calyx of Held synapses carrying either a single Munc13-1 H567K or a single Munc13-1 wt allele. Munc13-1 H567K/− synapses show enhanced initial strength but impaired steady-state release and slower recovery from depression. These deficits result from an increased initial abundance of fully primed SVs and a loss of activity-dependent acceleration of SV priming. Posttetanic potentiation (PTP) is strongly reduced in Munc13-1 H567K/− synapses and either increased or attenuated by C 2 B mutations that enhance or weaken Ca 2+ -phospholipid binding. Our data identify Munc13-1 as a target of presynaptic TrkB–phospholipase C–γ signaling and demonstrate that C 1 and C 2 B domain-dependent regulation of Munc13-1 determines synaptic strength and shapes short-term plasticity and PTP.
- 13 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (7) , eaea0449
Open AccessMunc13-1 couples DAG and Ca 2+ signaling to dynamic vesicle priming, synaptic short-term plasticity, and posttetanic potentiation
Synaptic strength and plasticity are fine-tuned by neuromodulation and use-dependent second-messenger signaling. Presynaptic diacylglycerol (DAG), Ca 2+ , and Ca 2+ -calmodulin signaling converge on the essential synaptic vesicle (SV) priming protein Munc13-1 via its regulatory C 1 , C 2 B, and CaM-binding domains. Using brainstem-specific heterozygous mice expressing a DAG-binding-deficient Munc13-1 variant (Munc13-1 H567K ), we compared synaptic transmission in situ at glutamatergic calyx of Held synapses carrying either a single Munc13-1 H567K or a single Munc13-1 wt allele. Munc13-1 H567K/− synapses show enhanced initial strength but impaired steady-state release and slower recovery from depression. These deficits result from an increased initial abundance of fully primed SVs and a loss of activity-dependent acceleration of SV priming. Posttetanic potentiation (PTP) is strongly reduced in Munc13-1 H567K/− synapses and either increased or attenuated by C 2 B mutations that enhance or weaken Ca 2+ -phospholipid binding. Our data identify Munc13-1 as a target of presynaptic TrkB–phospholipase C–γ signaling and demonstrate that C 1 and C 2 B domain-dependent regulation of Munc13-1 determines synaptic strength and shapes short-term plasticity and PTP.
- Open Access
- 22 October 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (11) , 2691-2704
Pathogenic UNC13A variants cause a neurodevelopmental syndrome by impairing synaptic function
The UNC13A gene encodes a presynaptic protein that is crucial for setting the strength and dynamics of information transfer between neurons. Here we describe a neurodevelopmental syndrome caused by germline coding or splice-site variants in UNC13A . The syndrome presents with variable degrees of developmental delay and intellectual disability, seizures of different types, tremor and dyskinetic movements and, in some cases, death in early childhood. Using assays with expression of UNC13A variants in mouse hippocampal neurons and in Caenorhabditis elegans , we identify three mechanisms of pathogenicity, including reduction in synaptic strength caused by reduced UNC13A protein expression, increased neurotransmission caused by UNC13A gain-of-function and impaired regulation of neurotransmission by second messenger signalling. Based on a strong genotype–phenotype-functional correlation, we classify three UNC13A syndrome subtypes (types A–C). We conclude that the precise regulation of neurotransmitter release by UNC13A is critical for human nervous system function.
- 22 October 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (11) , 2691-2704
Open AccessPathogenic UNC13A variants cause a neurodevelopmental syndrome by impairing synaptic function
The UNC13A gene encodes a presynaptic protein that is crucial for setting the strength and dynamics of information transfer between neurons. Here we describe a neurodevelopmental syndrome caused by germline coding or splice-site variants in UNC13A . The syndrome presents with variable degrees of developmental delay and intellectual disability, seizures of different types, tremor and dyskinetic movements and, in some cases, death in early childhood. Using assays with expression of UNC13A variants in mouse hippocampal neurons and in Caenorhabditis elegans , we identify three mechanisms of pathogenicity, including reduction in synaptic strength caused by reduced UNC13A protein expression, increased neurotransmission caused by UNC13A gain-of-function and impaired regulation of neurotransmission by second messenger signalling. Based on a strong genotype–phenotype-functional correlation, we classify three UNC13A syndrome subtypes (types A–C). We conclude that the precise regulation of neurotransmitter release by UNC13A is critical for human nervous system function.